That is very important, because the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be efficient. In other words, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been an experimental procedure (jeff brown predictions for 2021). Now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much easier to produce drugs that do what they're created to do. This was an advancement almost no one saw. However it's going to have extensive implications for treating illness. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be plenty of investment opportunities in this space, too. Moving subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (artificial intelligence). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it pulled back possibly substantially prior to going higher - united arab emirates. I've been covering bitcoin for a very long time now. Among the first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mainly informing readers. However that's not the big question anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. jeff brown investor prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are numerous fantastic personal business on the edge of striking the public markets And I've been dealing with a new method for you to invest even before these business go public.
This opportunity has actually been building over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the information. Go right here to schedule your spot for free.
Emma Walsh here, handling editor of the Journal. Regular Journal readers know that tech isn't our usual beat (jeff bezos). And when it concerns tech investing, we leave it to the experts. Luckily, we have numerous such experts in our Rolodex. Our coworker Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing experts we understand (jeff brown 2020 predictions). In truth, he had numerous triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and forecast what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and a lot more. These trends are experiencing exponential development and creating amazing opportunities for financiers. I want to ensure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. exponential growth. But in spite of what many readers might think, this is a pattern that's just getting going. Although the COVID-19 pandemic interfered with supply chains last year, an excellent 250 million 5G-enabled devices were still sold.
And all of this ultimately led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (black sea). Losing two months of production and sales actually affects how numerous 5G devices are offered in the fiscal year. When you consider all of that, offering 250 million units is amazing. More notably, the hold-ups brought on by the pandemic developed a load of bottled-up demand. Which need is now going to be pushed into 2021. In truth, I anticipate that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown top stock pick 2021. And that's not my only 5G prediction When I have actually talked about 5G in the past, I've described its three various phases.
In Stage Two, 5G devices go on sale. 5G phones and other items begin to reach consumers. And in Stage Three, 5G services begin to be offered (jeff brown biotech stock). That's when we begin to see applications working on 5G networks. Believe of things like massive multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Phase 3 by this summertime. This starts something of a virtuous cycle: Many people do not actually appreciate the technology. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being developed. In reality, 5G is going to open up a suite of incredible applications: self-driving automobiles, the Web of Things, robotic surgery, and more. All of these technologies require 5G. The financial investment chances moving forward will be huge. Stepping far from 5G, the next essential technology I anticipate in 2021 is CRISPR genetic editing. CRISPR represents "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it's one of the most interesting developments in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software application.
The program can crash or not function correctly. CRISPR uses a comparable idea however with our genetic code. "Typos" in our genome can result in illness. CRISPR can fix these "typos." For several years, CRISPR was primarily a niche technology that wasn't well understood. And during that time, there were really just three business operating in this area. However things are altering. CRISPR is no longer simply theoretical. We're seeing real results. We're treating illness and seeing that this innovation simply works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and providing amazing returns. This whole industry is effectively a greenfield opportunity.
There's space for lots of business to exist in this space. jeff brown investment prediction. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or 3 more hereditary editing business will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its latest Alpha, Fold software application can accurately forecast the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is necessary because the way a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error procedure. However now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're designed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but several drug therapies produced using this technology. This was one of those developments that practically nobody saw. However it's going to have extensive implications for treating illness. And, naturally, there will be plenty of financial investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it drew back possibly substantially prior to going greater. I have actually been covering bitcoin for a long period of time now. One of the very first research reports I ever published was on bitcoin - jeff brown prediction for 2021. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my suggestion. However at the time of that preliminary suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
But no one is asking that concern anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. jeff brown biotech pick. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the info depends on date as of February 2021, however we could not independently confirm this claim. Provided Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an accurate figure at this moment. Brown is best understood for his sage-like capability to choose winning innovation stocks. He spent more than 25 years researching technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience provides him an outstanding point of view on the marketplace. He's constantly on the hunt for new opportunities, and he shares much of his best choices in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an excellent reputation as a stock-picker, and he successfully predicted a few of the biggest financial occasions of the past twenty years. Although he does not appear to release his choices to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. No one on Wall Street gets it ideal each time, but Jeff Brown's accurate predictions have actually earned him legions of devoted fans. That says a lot about his capability. The Near Future Report is released by Brownstone Research, a prominent monetary research study publisher. Brownstone Research study offers a number of research study services with a wide range of specializations - second wave.
The company is also connected with Bonner & Partners, another well-respected research publisher - jeff brown tech stock 2021. On its website, Brownstone states its mission is to provide retail investors with professional-grade research study: "For too long, the very best financial investment research has not been offered to individual financiers. It has actually been normally scheduled for investment banks, hedge funds, private equity, and high-net-worth customers. diplomatic relations. The mission of Brownstone Research is to make that kind of proprietary research study available to any financiers aiming to get an edge in the marketplaces. The goal is basic to deliver unique and successful investment research discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise acts as the firm's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to provide its customers. After years of consistent success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout many of America. If you know even a little bit about the marketplace, you know that he has a reputation as a King Midas of sorts. jeff brown biotech pick. Whatever he touches relies on gold! Jeff is well mindful of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In truth, Brown believes S.A.V. jeff brown biotech genome sequencing. could be "the most significant trend of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next huge act will be weding two innovative innovations: expert system and electric automobiles. Musk hopes the combination will assist him establish the very first fully-autonomous, self-driving automobiles ever. It's absolutely nothing except the automotive industry's Holy Grail. As you know, electrical automobiles and self-driving vehicle stocks have been big this year, however the Wall Street maker has approved buzz without much tangible outcome. In spite of a drastic boost in competition over the past few years, Brown still thinks Musk has the finest chance of putting it all together.
tech might be the magic string that ties it all together. S.A.V. represents Shared Autonomous Lorry, and it might be the future of transport. Essentially, this innovation would permit you to lease your car as a self-governing, self-driving taxi when you're not using it. You just leave the cars and truck and press a button on an app that informs the cars and truck to "join the fleet." Next thing you understand, you're relaxing on your couch while your car shuttles ride-sharers around town. Most importantly, you get to keep a large chunk of the earnings. It sounds outrageous, but it could be closed than you think.